Uncategorized
Ocular Therapeutix™ to Participate at Three Upcoming Investor Conferences
BEDFORD, Mass.--(BUSINESS WIRE)---- $OCUL #OCUTX--Ocular Therapeutix, Inc. (Nasdaq: OCUL) a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today announced that it will participate at the following conferences: Jefferies Virtual Healthcare Conference Date: Tuesday, June 1, 2021 Analyst-hosted fireside chat: 4:00 PM ET The JMP Securities Life Sciences Conference Date: Wednesday, June 16, 2021 Analyst-hosted f